A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis

By Jo Jae-Cheol   Hong Yong   Kim Kyu-Pyo   Lee Jae-Lyun   Lee Jeeyun   Park Young   Kim Sun   Ryu Jin-Sook   Lee Jong-Seok   Kim Tae  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 369-376

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

By Sasaki Takashi  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 708-713

Springer Publishing Company

Access to resources Recommend Favorite

The combination of imexon and dacarbazine has shown potential in patients with advanced malignant melanoma

By  

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

By Ajani Jaffer   Jiang Yixing   Faust Josephine   Chang Baochong   Ho Linus   Yao James   Rousey Steven   Dakhil Shaker   Cherny Richard   Craig Catherine   Bleyer Archie  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 353-357

Springer Publishing Company

Access to resources Recommend Favorite

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study

By von Delius Stefan   Eckel Florian   Wagenpfeil Stefan   Mayr Martina   Stock Konrad   Kullmann Frank   Obermeier Florian   Erdmann Johannes   Schmelz Renate   Quasthoff Stefan   Adelsberger Helmuth   Bredenkamp Rainer   Schmid Roland   Lersch Christian  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite